Literature DB >> 1759123

Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples.

T Ihamäki1, P Sipponen, K Varis, M Kekki, M Siurala.   

Abstract

The aim of the study was to evaluate what family characteristics and what morphological, functional and immunological changes of the gastric mucosa precede the development of gastric malignancy in a follow-up of 11-14 years. The material consisted of 301 first-degree relatives of gastric carcinoma patients, 183 relatives of pernicious anaemia patients, and of 358 control relatives of probands computer matched from the general population by age and sex for the carcinoma probands. All subjects were endoscopically examined in 1973-1976 and followed up to the end of 1987. According to cancer registry data, 11 cases of malignant gastric tumours (9 carcinomas, one carcinoid tumour and one anaplastic tumour with suspicion of Hodgkin's disease) had been diagnosed during the follow-up: 6 belonged to gastric carcinoma, 2 to pernicious anaemia and 3 to control families. The occurrence of malignancy was significantly related to the presence of advanced gastritis with atrophy and of intestinal metaplasia before the start of the follow-up. In relatives with achlorhydria and low serum pepsinogen I levels the incidence of malignancy did not significantly differ from that in controls of similar age and sex distribution. The risk of getting malignancy was about four-fold in female members of gastric carcinoma and pernicious anaemia families but was not increased in control families. The risk was increased only in female members and concerned only gastric malignancy being the expected one or even lower than the expected in regard to malignancies of other location.

Entities:  

Mesh:

Year:  1991        PMID: 1759123     DOI: 10.3109/00365529109103982

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  9 in total

1.  Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Authors:  M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

Review 2.  The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.

Authors:  J Keller; T Schinke
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

3.  Gastric intestinal metaplasia: subtypes and natural history.

Authors:  H M El-Zimaity; J Ramchatesingh; M A Saeed; D Y Graham
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 4.  Assessing risks for gastric cancer: new tools for pathologists.

Authors:  Robert M Genta; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

5.  A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.

Authors:  M Dinis-Ribeiro; C Lopes; A da Costa-Pereira; M Guilherme; J Barbosa; H Lomba-Viana; R Silva; L Moreira-Dias
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

6.  DNA Methylation Predicts Progression of Human Gastric Lesions.

Authors:  Barbara G Schneider; Robertino Mera; M Blanca Piazuelo; Juan C Bravo; Jovanny Zabaleta; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Wael El-Rifai; Richard M Peek; Pelayo Correa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-12       Impact factor: 4.254

Review 7.  Helicobacter pylori eradication for preventing gastric cancer.

Authors:  Bin Lu; Meng Li
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 8.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

9.  Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis.

Authors:  E Solcia; G Rindi; R Fiocca; L Villani; R Buffa; L Ambrosiani; C Capella
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.